Skip to product information
RETATRUTIDE 32mg
R 1,995.00
Clinical Test Expectation
Retatrutide – Human Subjects: Leads to major fat loss (around 25% body weight) while largely preserving muscle. Unlike traditional GLP-1 drugs, it may increase energy expenditure, helping prevent metabolic slowdown. Participants show improved blood sugar control, insulin sensitivity, cholesterol levels, and liver health, alongside reduced appetite and food cravings. Side effects are mostly mild and temporary, mainly nausea early on. Overall, retatrutide is theoretically positioned as a next-generation metabolic and weight-loss therapy with broader benefits than current GLP-1 treatments.
Strength
32mg Per Vial.
Reconstitution
2ml of Bacteriostatic water into the vial of Retatrutide.
